We're investing over £280,000 to accelerate the development of new Parkinson's drugs
Date
News
Date
Through the Parkinson's Virtual Biotech, we're investing £1.1m to co-fund a study looking at whether a cough medicine, ambroxol, has the potential to slow the progression of Parkinson's.
Date
Parkinson's UK has awarded a new physical activity grant to Rock Steady Boxing. The grant will help train up to 10 new boxing coaches in high intensity, non-contact boxing for the Parkinson's community.
Date
From exciting research breakthroughs, to running marathons. We're celebrating all of our community's fantastic achievements this year.
Date
Results from a clinical trial looking at reducing iron levels in the brain have shown no benefit for unmedicated people with Parkinson's.
Date
Light therapy as a potential treatment for Parkinson's hits the headlines. We take a deeper look at what we know about it so far.
Date
Parkinson's UK campaigners handed in over 1,200 signed postcards to the Department of Health and Social Care, calling for investment in training on Parkinson's-related dementia for social care staff.
Date
Back in the summer, we called upon the Parkinson's community to take part in 5 clinical trials that were at a potential risk of closing. Thanks to you, we had an incredible response and want to keep up the momentum of encouraging people to take part in research.
Date
The biotech company NRG Therapeutics has received a large investment to continue its drug development project into life-changing new treatments.
Date
An international clinical trial looking at using stem cells to treat Parkinson's has been granted approval to go ahead initially in Sweden.
Date
We're investing £2m in Enterin's phase 2 clinical trial of its drug ENT-01, a potential treatment for Parkinson's dementia.